Alpha Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-15,951
Closed -$1.43M 96
2018
Q3
$1.43M Buy
15,951
+1,044
+7% +$92.3K 0.57% 65
2018
Q2
$1.18M Buy
14,907
+3,508
+31% +$291K 0.48% 71
2018
Q1
$1.02M Buy
11,399
+764
+7% +$73.3K 0.44% 67
2017
Q4
$1.11M Sell
10,635
-12
-0.1% -$1.35K 0.52% 62
2017
Q3
$1.55M Sell
10,647
-131
-1% -$17.8K 0.74% 41
2017
Q2
$1.4M Buy
10,778
+463
+4% +$56.7K 0.69% 43
2017
Q1
$1.28M Sell
10,315
-533
-5% -$63.8K 0.9% 39
2016
Q4
$1.26M Sell
10,848
-399
-4% -$44.4K 0.86% 41
2016
Q3
$1.18M Buy
+11,247
New +$1.22M 0.85% 50

Other funds holding CELG

Alpha Capital Management's CELG Position: Q4 2018 in Review

Alpha Capital Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 15,951 shares — an estimated $1.43M sold.

Alpha Capital Management first reported a position in CELG in Q3 2016 and held it in 9 quarters. The position peaked at $1.55M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Alpha Capital Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Alpha Capital Management sold 15,951 Celgene Corp shares in Q4 2018, an estimated $1.43M.
  • Alpha Capital Management first reported a position in Celgene Corp in Q3 2016 and held it in 9 quarters.
  • Alpha Capital Management's Celgene Corp position peaked at $1.55M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Alpha Capital Management's 13F filing for Q4 2018, filed 8 Feb 2019.